Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Retinal Cell Neoplasm — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Eye Neoplasm
Retinal Neoplasm
Retinal Cell Neoplasm

Subtype

Retinal Cell Neoplasm

CI-CAN-00001460Explore in graph →

Non-malignant15 active trials1 approved drugs2 evidence items

NCIt: C7061

Overview
Statistics
Survival
Genomics2
Variants & evidence2
Drugs
Trials110
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 46 Unknown 18 Recruiting 17 Terminated 13 Active Not Recruiting 8 Withdrawn 5 Enrolling By Invitation 2 Not Yet Recruiting 1

PhaseAll Early Phase 1 3 N/A 17 Phase 1 22 Phase 2 27 Phase 3 7 Phase 4 3

No study matches these filters